Talking Genomes with Your Patients. Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology

Similar documents
FIRST NAME MI LAST NAME BIRTH DATE (MM/DD/YYYY) GENDER. Name of person previously tested and relationship:

Illumina Clinical Services Laboratory

GeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information

GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Shawnia Ryan, MS, LCGC Senior Genetic Counselor University of New Mexico Cancer Center

Precision Medicine and Genetic Counseling : Is Yes always the correct answer?

Genetic Counselling in relation to genetic testing

BRCAnowTM It s Your Decision

Movement Disorders Requisition Form

GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center

BRCA Precertification Information Request Form

Genetic testing for hereditary cancer. An overview for healthcare providers

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

Genetics and Genetic Testing for Autism:

Applies to: All Aetna plans, except Traditional Choice plans. All Innovation Health plans, except indemnity plans

CONSENT TO GENETIC TESTING THROUGH A RESEARCH STUDY

Hypertrophy of liver Neonatal hypoglycemia Omphalocele Large for gestational age Other:

EVOLVE CARRIER GENETIC SCREENS. Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW.

Genomics for Rare Diseases

CNNH NeuroGenomics Program Peer-to-Peer Service Consent/Information Form

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor

Genetic causes 90% Other causes 10% No variants are found in known genes associated with ADPKD

DNA Basics. We are all made up of cells. Cells contain DNA, or instructions to tell our bodies how to work.

I have ovarian cancer

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.

Corporate Medical Policy

Notes for slide 2 Welcome to today s training webinar. We appreciate everyone taking time today to hear our presentations. We are very excited to fina

JULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology

Intellectual Disability Exome Panel Requisition Form

Female Demographic Information

Genetics/Genomics: role of genes in diagnosis and/risk and in personalised medicine

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

The Six Ws of DNA testing A scenario-based activity introducing medical applications of DNA testing

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS

INTRODUCTION. Marian Reiff Impact of genome-wide testing APHA Boston 2013

YES. If yes, indicate what types of tumors/polyps and age of onset:

Why Pathway Genomics. Advanced Genetic Testing Laboratory. General Health and Wellness. Liquid Biopsy. Hereditary Cancer.

What is New in Genetic Testing. Steven D. Shapiro MS, DMD, MD

Introduction to Evaluating Hereditary Risk. Mollie Hutton, MS, CGC Certified Genetic Counselor Roswell Park Comprehensive Cancer Center

Epilepsy Genetics Service Kings College Hospital & St Thomas s Hospital, London

The Patient Perspective: diagnostic Exome Sequencing

Understanding The Genetics of Diamond Blackfan Anemia

BRCA1 and BRCA2. patient guide. genetic testing for hereditary breast and ovarian cancer (hboc)

SHARSHERET. New Recommendations for Genetic Testing: How Do I Make Sense Of It All?

A guide to genetic testing for hereditary cancers

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

Case Presentation and Discussion: Breast Cancer. Madhuri Rao, MD PGY-5 SUNY Downstate Medical Center

I have ovarian cancer

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Benefits and pitfalls of new genetic tests

PALB2 c g>c is. VARIANT OF UNCERTAIN SIGNIFICANCE (VUS) CGI s summary of the available evidence is in Appendices A-C.

Counsyl Foresight Carrier Screen. Utmost confidence in every result

A Guide for Understanding Genetics and Health

Personalis ACE Clinical Exome The First Test to Combine an Enhanced Clinical Exome with Genome- Scale Structural Variant Detection

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18

Genetics update and implications for (General) Practice

Sample Test Report. Mayo Clinic GeneGuide. Report. Consumer Name DOB: 00/00/0000

A Guide for Understanding Genetics and Health

patient guide Clinical Genomics genetic testing for undiagnosed diseases Taking the extra step to find answers

PATIENT EDUCATION. carrier screening INFORMATION

TEST INFORMATION Test: CarrierMap GEN (Genotyping) Panel: CarrierMap Expanded Diseases Tested: 311 Genes Tested: 299 Mutations Tested: 2647

PATIENT EDUCATION. Cystic Fibrosis Carrier Testing

Neurological Disorders

ICARE Initiative. Cristi Radford, MS, CGC ICARE Outreach Coordinator

Genetics: More Than 23 and Me

Neurogenetics Genetic Testing and Ethical Issues

Microarray Comparative Genomic Hybridisation (array CGH)

The impact of hereditary breast and ovarian cancer (HBOC) syndrome testing on patient management and your practice

MNGenome Sequencing Test Request Form

Exome Requisition Form

NEBRASKA OCA PEER SUPPORT & WELLNESS SPECIALIST TRAINING APPLICATION January 23-27, 2012, Kearney, NE

No mutations were identified.

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

A Guide for Understanding Genetics and Health

certain genotypes known to be associated with genetic disease or a predisposition to genetic disease

Importance of Clinical Information for Optimal Genetic Test Selection and Interpretation

So how much of breast and ovarian cancer is hereditary? A). 5 to 10 percent. B). 20 to 30 percent. C). 50 percent. Or D). 65 to 70 percent.

DNA is the genetic material that provides instructions for what our bodies look like and how they function. DNA is packaged into structures called

Carrier Screening in your Practice Is it Time to Expand your View?

patient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention

Commonly asked questions about genetic testing for hereditary cancer

Russell-Silver syndrome (RSS)

Clinical Genetics Welcome to Clinical Genetics

Genetic Carrier Testing Cystic Fibrosis (CF) Spinal Muscular Atrophy (SMA) Fragile X Syndrome

Universal BRCA1 and BRCA2 Genetic Testing for Ovarian Cancer Patients

Does Cancer Run in Your Family?

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

Lynch Syndrome. patient guide. genetic testing for hereditary colorectal and uterine cancer

Gene Sequencing in Newborn Screening: Covering the Bases of Education and Follow-Up. Amy Gaviglio, MS, CGC February 17, 2017

Integrating the Latest in Genomic Science into Modern Medical Practice

Approach to the Genetic Diagnosis of Neurological Disorders

Application to be an additional provider for existing test on the NHS Directory of Molecular Genetic Testing Additional Provider form

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

110 DISEASES 3 DISEASES GENE TIC COUNSELING CARRIERMAP Recombine. Others. 30+ minute clinical genetic counseling session.

Cystic Fibrosis Carrier Testing

Sequencing. Deletion/Duplication Analysis. How Does Genetic Testing for Cancer Work?

PERSONALIZED GENETIC REPORT CLIENT-REPORTED DATA PURPOSE OF THE X-SCREEN TEST

Jill Stopfer, MS, CGC Abramson Cancer Center University of Pennsylvania

Telephone Disclosure Visual Aid Toolkit: Panel Testing

helpful guide Carrier Testing for Common Genetic Diseases Hemoglobinopathies Cystic Fibrosis Spinal Muscular Atrophy Fragile X

FAMILY PLANNING DOESN T HAVE TO BE ONE OF THEM

Transcription:

Talking Genomes with Your Patients Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology

Objectives Review the importance of physician familiarity with genomic testing and results Explore common patient (and physician) misconceptions and re-education techniques Discuss strategies for pre- and post-test conversations with your patients Identify resources for genetic and genomic information for patients and providers

Why Does This Matter?

You may be the sole source of genetic information for your patients There are not enough genetic counselors/ geneticists to handle every patient or every test that needs to be done Genetics/genomics is becoming more ubiquitous and will be incorporated into healthcare of individuals along the health spectrum Even if you don t order any genetic tests, a patient will eventually bring in a test report and expect you to know what to do with it Population: 4.85 million

Common Misconceptions

Misconception 1: No one in my family has any genetic diseases, so I and my children are not at risk

Small families Confounding histories Unknown family history De novo pathogenic variants P Recessive conditions

Misconception 2: I m the first person in my family with this disease, so it can t be genetic

Small families Unknown family history Reduced penetrance Variable expressivity +/+ +/+ De novo pathogenic variants Recessive conditions +/c.42g>a

Misconception 3: This condition runs in my family, so it must be genetic

Common diseases Family members share genes, but also environmental and lifestyle factors Having affected family members does increase risk for many conditions

Misconception 4: Even if this test is positive, it s not going to change anything what s the point?

Avoid additional tests Stop asking why? May indicate treatment Benefits of a Genetic Diagnosis Recurrence risk May change surveillance Life/financial planning

Misconception 5: I ve already had genetic testing, so I don t need whole genome sequencing

Karyotype Microarray Chr 1 Chr 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Chr 7 Chr 7 15 16 17 18 19 20 21 22 23 24 25 26 27 28 Chr 18 Chr 18 29 30 31 32 33 34 35 36 37 38 39 40 41 42 Chr X Chr X 43 44 45 46 47 48 49 50 51 52 53 54 55 56 Cost: $500-1200 Cost: $1500-3000

Single site mutation Sequencing a single gene Chr 1 Chr 1 Chr 7 Chr 7 A or C? Chr 18 Chr 18 Chr X Chr X Sequencing a panel of genes Exome sequencing Chr 1 Chr 1 Chr 7 Chr 7 Chr 18 Chr 18 Chr X Chr X

Genome sequencing Chr 1 Chr 7 Chr 18 Chr X

Misconception 6: My whole genome sequencing was negative, so my disease must not be genetic

Limits of 2016 Knowledge ~20,000 human genes Only ~5,000 have been definitively associated with human disease Variants of uncertain significance in genes that are not well known may not be reported Causative variants may not be identified with WGS due to limitations of technology

Misconception 7: Whole genome sequencing can tell me about my risk for any/all diseases

Common, complex diseases Multifactorial conditions Threshold model

Dealing with Misconceptions 1. Elicit the misconception 2. Identify the misconception 3. Deconstruct the misconception 4. Replace the misconception

Pre- and Post-Test Discussion Points

Before You Order a Genome: 1. Is there another test that would be more 1. Patient Information Patient Name Last TEST REQUISITION, PATIENT INFORMATION, AND CONSENT HUDSONALPHA CLINICAL SERVICES LAB (4/2016) HUDSONALPHA CLINICAL SERVICES LAB CANNOT ACCEPT SAMPLES FROM FLORIDA, MARYLAND, NEW YORK, RHODE ISLAND, AND TENNESSEE. First Medical Record Number HudsonAlpha Clinical Services Lab, LLC 601 Genome Way, Rm 3023 Huntsville, AL 35806 256-327-0438 test@clinicallab.org Date of Birth / / Gender Male Female Unknown Ethnic Ancestry Month Day Year African American Hispanic Ashkenazi Jewish Caucasian Middle Eastern Other: Asian/Pacific Islander Native American appropriate for your patient? 2. Pertinent Clinical Information DIAGNOSES ICD10 Code(s) REQUIRED: a copy of physician s note about the patient, including family history Not needed if samples are submitted for extraction and storage or return of data without analysis. 2. Does your patient have reasonable expectations of the potential results of testing? 3. Has the patient had the opportunity to make OPTIONAL: photo of patient Date Sample Obtained (MM/DD/YYYY) Sample Type (Check all that apply) Blood (EDTA) Oncology specimen? Yes No DNA (Extracted) Saliva 3. Ordering Physician Information Deliver report to: Name: Telephone: Department: Fax: Address: Email: Ordering Physician: (Print Name) Who should the laboratory contact with questions about this case? (Signature) appropriate choices regarding testing, and are they confident in their choices?

After You Receive a Report - Primary Findings Positive Provide information and resources to family Make appropriate specialist referrals Follow guidelines for surveillance/management if available Potential Primary Results VUS Counsel regarding uncertainty Investigate research opportunities Check for classification updates Negative Discuss limitations of a negative Consider additional clinical evaluations Consider reanalysis in 1-2 years

After You Receive a Report - Secondary Findings Diagnostic Interpret in context of medical/family history Review implications for family members Make appropriate specialist referrals Potential Secondary Results Carrier Status Discuss recessive inheritance - patient not affected Review implications for family members Facilitate testing for other family members Predictive Interpret in context of medical/family history Review implications for family members Refer for additional genetic counseling

Where Can I Get More Information?

P: 256-327-9640 Web: smithfamilyclinic.org P: 256-327-9670 Web: clinicallab.org

Questions?